HealthCor Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $36.4M | Buy |
321,380
+67,880
| +27% | +$7.69M | 33.35% | 2 |
|
|
2022
Q3 | $20.4M | Buy |
253,500
+178,720
| +239% | +$14.4M | 2.55% | 16 |
|
|
2022
Q2 | $5.57M | Buy |
+74,780
| New | +$5.57M | 0.56% | 36 |
|
|
2021
Q3 | – | Sell |
-203,560
| Closed | -$21.7M | – | 76 |
|
|
2021
Q2 | $21.7M | Sell |
203,560
-364,880
| -64% | -$39M | 0.87% | 35 |
|
|
2021
Q1 | $51.1M | Buy |
+568,440
| New | +$51.1M | 1.81% | 21 |
|
|
2019
Q2 | – | Sell |
-2,920,400
| Closed | -$87M | – | 53 |
|
|
2019
Q1 | $87M | Sell |
2,920,400
-2,954,608
| -50% | -$88M | 3.51% | 10 |
|
|
2018
Q4 | $176M | Buy |
5,875,008
+3,976,288
| +209% | +$119M | 5.5% | 2 |
|
|
2018
Q3 | $67.9M | Sell |
1,898,720
-559,800
| -23% | -$20M | 2.25% | 20 |
|
|
2018
Q2 | $58.4M | Buy |
+2,458,520
| New | +$58.4M | 1.85% | 22 |
|
|
2017
Q2 | – | Sell |
-900,000
| Closed | -$19.1M | – | 40 |
|
|
2017
Q1 | $19.1M | Sell |
900,000
-614,600
| -41% | -$13M | 0.87% | 28 |
|
|
2016
Q4 | $22.6M | Buy |
+1,514,600
| New | +$22.6M | 1.28% | 23 |
|
|
2016
Q3 | – | Sell |
-1,584,120
| Closed | -$31.4M | – | 39 |
|
|
2016
Q2 | $31.4M | Sell |
1,584,120
-5,515,880
| -78% | -$109M | 1.71% | 20 |
|
|
2016
Q1 | $121M | Buy |
7,100,000
+4,100,000
| +137% | +$69.6M | 6.83% | 3 |
|
|
2015
Q4 | $61.4M | Buy |
3,000,000
+2,900,000
| +2,900% | +$59.4M | 3.73% | 11 |
|
|
2015
Q3 | $2.15M | Sell |
100,000
-970,000
| -91% | -$20.8M | 0.12% | 40 |
|
|
2015
Q2 | $21.4M | Buy |
+1,070,000
| New | +$21.4M | 1.08% | 25 |
|